Concepedia

Lai Wei

LW

Statistics

Publications

163

Citations

7.6K

H-Index

45

Active since

2003

Affiliations

The Ohio State University(Current)

The Ohio State University Wexner Medical Center

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Nationwide Children's Hospital

Lai Wei is an author at The Ohio State University specializing in medicine, oncology, and pharmacology.

ORCID

Publications per year

2003–2024

163

Publications

163

Phase II Trial of Sorafenib in Metastatic Thyroid Cancer

Richard T. Kloos, Matthew D. Ringel, Michael V. Knopp et al. · Journal of Clinical Oncology · 2009 · 543 citations · Full text

, , +17

Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals

Sarah E. M. Herman, Amber Gordon, Amy J. Wagner et al. · Blood · 2010 · 541 citations · Full text

, , +16

Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer

Elaine T. Lam, Matthew D. Ringel, Richard T. Kloos et al. · Journal of Clinical Oncology · 2010 · 375 citations

, , +9

Between-speaker and within-speaker variation in speech tempo of American English

Ewa Jacewicz, Robert A. Fox, Lai Wei · The Journal of the Acoustical Society of America · 2010 · 196 citations · Full text

, , +16

Interleukin-1β Selectively Expands and Sustains Interleukin-22+ Immature Human Natural Killer Cells in Secondary Lymphoid Tissue

Tiffany Hughes, Brian Becknell, Aharon G. Freud et al. · Immunity · 2010 · 194 citations · Full text

, , +14

1–5 of 163